相关实验视频

Updated: Sep 19, 2025

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

Published on: March 15, 2024

埃泽提米布工程L14-8通过激活PLK1/TP53-SAT1诱导的铁灭症来抑制晚期前列腺癌

Yu Zhang^1,2, Xiao-Wen Song³, Na Zhang⁴

¹Shanghai Frontiers Science Center for Chinese Medicine Chemical Biology, Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)

|June 19, 2025

概括

一种来自ezetimibe的新药,L14-8,通过诱导铁亡,有效治疗晚期前列腺癌. 这种疗法可以独立于雄激素受体信号,为耐药和致命病例提供希望.

科学领域:

在瘤学瘤学.
药理学药理学是指药理学的学科.
分子生物学分子生物学

背景情况:

转移性前列腺癌 (PCa) 患者经常对雄激素受体信号抑制剂 (ARSI) 产生耐药性.
神经内分泌前列腺癌 (NEPC) 成为致命的,AR独立的进展,治疗选择有限.

研究的目的:

开发针对晚期和致命的前列腺癌的新型AR独立治疗方法.
研究L14-8的抗癌作用和机制,L14-8是一种来自ezetimibe的新型小分子.

主要方法:

检测小分子的AR-独立抗癌活性.
在体外研究评估L14-8对前列腺癌细胞生长和ferroptosis诱导的影响.
涉及PLK1降解,TP53酸化和SAT1转录的机制研究.
在临床前模型中对L14-8的体内疗效和毒性研究.

主要成果:

通过诱导铁亡,L14-8显著抑制了晚期前列腺癌细胞的生长.
L14-8促进了普利克1的普利基因介导降解,从而增加了p53酸化和SAT1转录.
在体内,L14-8表现出强大的抗瘤疗效,没有显著的毒性.

结论:

L14-8代表了一种有前途的新型治疗药物,用于致命的前列腺癌,通过AR-独立的铁亡作用.
PLK1-TP53-SAT1轴是L14-8抗癌作用的关键媒介.
这项研究为抗AR和NEPC提供了一个新的治疗策略.

关键词:

在SAT1中,SAT1是SAT1.这就是TP53的特点.药物设计和优化药物设计和优化铁性化 (ferroptosis) 是一种前列腺癌是前列腺癌.

更多相关视频

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

Published on: September 18, 2013

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Published on: January 18, 2017

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

PI3K/mTOR/AKT Signaling Pathway

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...